All patients (n=75) Standard of care (n=37) Heparin (n=38) P-value
Age (y) 51.95 ± 12.39 52.63 ± 12.48 51.26 ± 12.27 0.688
Male (n,%) 48 (63%) 25 23  N/A
Caucasian 65 (85%) 35 30 N/A
Body Mass Index (kg/m2) 30.65 ± 6.19 29.79 ± 6.02 31.44 ± 6.23 0.3897
Time from symptom onset (days) 8.61 ± 4.15 8.97 ± 5.10 8.26 ± 2.85 0.9329
Time to commencement of inhaled UFH (hours) N/A N/A 4 N/A
Modified ordinal scale at baseline (average) 4.23 ±0.57 4.14 ± 0.58 4.32 ± 0.61 0.2054
WHO SCORE Number of patients Number of patients Number of patients Number of patients
1 2 3 4 5 6 7 0 0 8 44 24 0 0 0 0 4 24 9 0 0 0 0 4 20 15 0 0
N/A